Atomo Diagnostics is delighted to announce the company has won the Advance Queensland Johnson & Johnson Innovation QuickFire Challenge.
The win, which comes with $100, 000 in funding to deliver a ‘proof of concept’ program, was announced by the Premier of Queensland, Annastacia Palaszczuk, at the QUT Institute of Health & Biomedical Innovation.
CEO John Kelly said, “We gratefully thank the Queensland Government and Johnson & Johnson Innovation for their support. This funding will allow us to evaluate the feasibility of an easy-to-use test for the early detection of heart attacks away from laboratory and hospital settings.”
Atomo Diagnostics will partner with Brisbane-based Anteo Technologies to develop a clinical prototype of a cost effective and accurate point of care test for the diagnosis of heart attacks. Subject to a successful proof of concept phase, Atomo and Anteo will consider options to fully commercialise an AtomoRapid based solution for the cardiac market.